Impact of Provoking Risk Factors on the Prognosis of Cerebral Venous Thrombosis in Korean Patients
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose Little is known about the relationships between provoking risk factors, prognosis, and optimal duration of anticoagulation in patients with cerebral venous thrombosis (CVT), especially in Asians. We aimed to investigate whether the prognosis and required duration of anticoagulation in CVT patients differ according to the provoking risk factors. Methods Prospectively recorded data from a tertiary medical center in South Korea were retrospectively reviewed. CVTs were categorized into three groups: unprovoked, those with possibly resolved provoking factors (PR), and those with persistent provoking factors (PP). The baseline characteristics, treatment, and prognosis of patients in these three groups were analyzed. Results From 2000 to 2015, 61 patients presented with CVT: 19 (31.1%) unprovoked, 11 (18.0%) with PR, and 31 (50.9%) with PP. The patients in our cohort had a slight female predominance and lower frequency of oral contraceptive use compared to Western cohorts. Median follow-up and duration of anticoagulation were 35 and 8 months, respectively. Despite the similarities in baseline characteristics, deaths (n = 3; P= 0.256) and recurrences (n = 7; P= 0.020) were observed only in the PP group. The median intervals to death and recurrence were 9 and 13 months, respectively. Death was associated with underlying disease activity, not with CVT progression. Recurrences in the PP group were associated with lack of anticoagulation (P= 0.012). Conclusions Although the prognosis of CVT is generally benign in Koreans, recurrence and death were observed in patients with persistent risk factors, suggesting their need for long-term treatment with anticoagulants.
Abstract
Background and Purpose Little is known about the relationships between provoking risk factors, prognosis, and optimal duration of anticoagulation in patients with cerebral venous thrombosis (CVT), especially in Asians. We aimed to investigate whether the prognosis and required duration of anticoagulation in CVT patients differ according to the provoking risk factors. Methods Prospectively recorded data from a tertiary medical center in South Korea were retrospectively reviewed. CVTs were categorized into three groups: unprovoked, those with possibly resolved provoking factors (PR), and those with persistent provoking factors (PP). The baseline characteristics, treatment, and prognosis of patients in these three groups were analyzed. Results From 2000 to 2015, 61 patients presented with CVT: 19 (31.1%) unprovoked, 11 (18.0%) with PR, and 31 (50.9%) with PP. The patients in our cohort had a slight female predominance and lower frequency of oral contraceptive use compared to Western cohorts. Median follow-up and duration of anticoagulation were 35 and 8 months, respectively. Despite the similarities in baseline characteristics, deaths (n = 3; P= 0.256) and recurrences (n = 7; P= 0.020) were observed only in the PP group. The median intervals to death and recurrence were 9 and 13 months, respectively. Death was associated with underlying disease activity, not with CVT progression. Recurrences in the PP group were associated with lack of anticoagulation (P= 0.012). Conclusions Although the prognosis of CVT is generally benign in Koreans, recurrence and death were observed in patients with persistent risk factors, suggesting their need for long-term treatment with anticoagulants.
참고문헌 (30)
- Stam J, "Thrombosis of the cerebral veins and sinuses", N Engl J Med, 352, pp.1791~1798 (2005)
- Dentali F, "Natural history of cerebral vein thrombosis : a systematic review", Blood, 108, pp.1129~1134 (2006)
- Piazza G, "Cerebral venous thrombosis", Circulation, 125, pp.1704~1709 (2012)
- Saposnik G, "Diagnosis and management of cerebral venous thrombosis : a statement for healthcare professionals from the American Heart Association", American Stroke Association, 2011, pp.42, 1158~1192
- Martinelli I, "Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis", Circulation, 121, pp.2740~2746 (2010)
- Wasay M, "Cerebral venous thrombosis : analysis of a multicenter cohort from the United States", J Stroke Cerebrovasc Dis, 17, pp.49~54 (2008)
- Khealani BA, "Cerebral venous thrombosis : a descriptive multicenter study of patients in Pakistan and Middle East", Stroke, 39, pp.2707~2711 (2008)
- Coutinho JM, "Declining mortality in cerebral venous thrombosis : a systematic review", Stroke, 45, pp.1338~1341 (2014)
- Ferro JM, "Prognosis of cerebral vein and dural sinus thrombosis : results of the International Study on Cerebral Vein and Dural Sinus Thrombosis(ISCVT)", Stroke, 35, pp.664~670 (2004)
- Martinelli I, "High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives", N Engl J Med, 338, pp.1793~1797 (1998)
- Lanska DJ, "Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis", Stroke, 31, pp.1274~1282 (2000)
- Raizer JJ, "Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patients", Neurology, 54, pp.1222~1226 (2000)
- Martinelli I, "Hyperhomocysteinemia in cerebral vein thrombosis", Blood, 102, pp.1363~1366 (2003)
- Vidailhet M, "Cerebral venous thrombosis in systemic lupus erythematosus", Stroke, 21, pp.1226~1231 (1990)
- Farah S, "Behcet’s syndrome : a report of 41 patients with emphasis on neurological manifestations", J Neurol Neurosurg Psychiatry, 64, pp.382~384 (1998)
- Kim MJ, "Recurrent Cerebral Venous Thrombosis Associated with Elevated Factor VIII", J Clin Neurol, 2, pp.286~289 (2006)
- Maqueda VM, "Risk of thromboembolism after cerebral venous thrombosis", Eur J Neurol, 13, pp.302~305 (2006)
- Preter M, "Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients", Stroke, 27, pp.243~246 (1996)
- Breteau G, "Cerebral venous thrombosis 3-year clinical outcome in 55 consecutive patients", J Neurol, 250, pp.29~35 (2003)
- Cakmak S, "Cerebral venous thrombosis : clinical outcome and systematic screening of prothrombotic factors", Neurology, 60, pp.1175~1178 (2003)
- Coutinho JM, "Association Between Anemia and Cerebral Venous Thrombosis: Case-Control Study", Stroke (2015)
- Gosk-Bierska I, "Cerebral venous sinus thrombosis : Incidence of venous thrombosis recurrence and survival", Neurology, 67, pp.814~819 (2006)
- Cundiff DK, "Anticoagulants for cerebral venous thrombosis:harmful to patients?", Stroke, 45, pp.298~304 (2014)
- Coutinho JM, "Anticoagulation for cerebral venous sinus thrombosis", Stroke, 43, pp.e41~e42 (2012)
- Jaff MR, "Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association", Circulation, 123, pp.1788~1830 (2011)
- Goldhaber SZ, "Optimal duration of anticoagulation after venous thromboembolism", Circulation, 123, pp.664~667 (2011)
- Selim M, "Cerebral venous thrombosis : another heparin controversy", Stroke, 45, pp.8~9 (2014)
- Crowther MA, "Congenital thrombophilic states associated with venous thrombosis : a qualitative overview and proposed classification system", Ann Intern Med, 138, pp.128~134 (2003)
- Tsai LK, "Intracranial dural arteriovenous fistulas with or without cerebral sinus thrombosis : analysis of 69 patients", J Neurol Neurosurg Psychiatry, 75, pp.1639~1641 (2004)